Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

102 Press Releases
DateTitleCompany
17 Mar 14 Ligand Earns $1 Million Milestone Payment Triggered by FDA Approval of Merck’s NOXAFIL® (posaconazole) Injection for Intravenous Use, a New Captisol-enabled Formulation Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
10 Mar 14 Captisol® Licensee Lundbeck Announces FDA Acceptance of NDA Submission for Carbamazepine IV Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
28 Feb 14 Ligand Partner GlaxoSmithKline Submits U.S. Regulatory Application for Promacta® (eltrombopag) for Severe Aplastic Anaemia Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
10 Feb 14 Ligand to Receive $1 Million Kyprolis® Commercial Milestone Payment from Onyx Pharmaceuticals Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
03 Feb 14 Ligand Partner GlaxoSmithKline Gains FDA Breakthrough Therapy Designation for Promacta®/Revolade® for Severe Aplastic Anemia Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
29 Jan 14 Ligand to Report Fourth Quarter Results on February 11th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
09 Dec 13 Ligand Announces Positive Preclinical Data on Small-Molecule G-CSF Receptor Agonist at the 55th Annual Meeting of the American Society of Hematology Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
12 Nov 13 Ligand Initiates Phase 1 Trial with Glucagon Receptor Antagonist for Type 2 Diabetes Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
07 Nov 13 Reminder: Ligand to Host Analyst Day on November 14th in Chicago Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
14 Oct 13 Ligand to Host Analyst Day on November 14th in Chicago Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
09 Oct 13 Ligand to Report Third Quarter Results on October 30th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
07 Oct 13 Ligand Announces FDA Acceptance of Investigational New Drug Application for Glucagon Receptor Antagonist Program Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
03 Oct 13 Ligand Partner Pfizer Receives FDA Approval for DUAVEETM for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
24 Sep 13 Ligand Partner GSK Receives Marketing Authorization from the European Commission for Additional Revoladeâ„¢ (Eltrombopag) Indication as the First Approved Treatment for Chronic Hepatitis C-Associated Thrombocytopenia Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
14 Aug 13 Ligand Enters Global License Agreement with CURx Pharmaceuticals, Inc. for Captisol-EnabledTM Topiramate Injection Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
26 Jul 13 Ligand Receives Orphan Designation for Captisol-EnabledTM Topiramate Injection Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
24 Jul 13 Ligand Signs License Agreement with Ethicor for Oral Lasofoxifene Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
22 Jul 13 Ligand Signs Global License Agreement with Azure for Lasofoxifene Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
16 Jul 13 Ligand to Report Second Quarter Results on August 1st Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
24 Jun 13 Ligand Announces Positive Preclinical Data for Glucagon Program in Model of Type 1 Diabetes Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
29 May 13 Ligand Provides New Corporate Presentation at Investor Conference Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
30 Apr 13 Ligand Acquires Financial Rights to More Than 15 Fully-Funded Development Programs from Selexis SA Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
26 Apr 13 Ligand Presents Preclinical Data on HepDirectâ„¢ Liver-Targeting Technology Platform at 2013 International Liver Congress (EASL) Annual Meeting Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
23 Apr 13 Ligand to Present at Upcoming Investor Conferences Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
22 Apr 13 Ligand to Report First Quarter Results on May 8th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
25 Feb 13 Ligand Receives $1.4 Million Milestone Payment from Retrophin, Inc. Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
14 Feb 13 Ligand Reports Fourth Quarter and Full Year 2012 Financial Results Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
23 Jan 13 Ligand to Report Fourth Quarter Results on February 13th Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
09 Jan 13 Ligand Receives Equity Milestone Payment from Retrophin Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
14 Dec 12 U.S. Food and Drug Administration (FDA) Accepts New Drug Application For Bazedoxifene/Conjugated Estrogens, An Investigational Treatment For Symptoms Associated With Menopause And Prevention of Osteoporosis Ligand Pharmaceuticals Incorporated,
Published by
Business Wire
Advertising